Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Multicenter Observational Study to Determine the Long-term Tolerability and Analgesic Effectiveness of Oral Tapentadol in Patients Suffering From Severe Pain Syndromes, Refractory to Other Strong Opioids.

NCT03814993 is registered in ClinicalTrials.gov with Dafne Balemans as lead sponsor.

NCT NCT03814993
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03814993 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Multicenter Observational Study to Determine the Long-term Tolerability and Analgesic Effectiveness of Oral Tapentadol in Patients Suffering From Severe Pain Syndromes, Refractory to Other Strong Opioids.
Lead sponsor
Dafne Balemans
Phase
Observational
Overall status
Completed
Start date
July 29, 2019
Completion date
August 1, 2021
Enrollment
55 (actual)
Sites
11

Conditions

As the registry lists them; a condition with its own page is linked.

severe pain syndromes